MTOR and benign neoplasm: TSC is an autosomal dominant neurocutaneous genetic disorder caused by a mutation in TSC 1 or TSC 2 gene [1], which in turn causes over-activation of mammalian target of rapamycin (mTOR) pathway, leading to formation of multiple benign tumors or hamartomas within various organs, including the brain, kidney, and heart [2].